Atossa Therapeutics
ATOS
#10704
Rank
NZ$43.55 M
Marketcap
NZ$4.36
Share price
0.00%
Change (1 day)
153.02%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): NZ-$7.02

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$7.29. In 2025 the company made an earnings per share (EPS) of NZ-$7.20 a decrease over its 2024 EPS that were of NZ-$5.42.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$7.02-2.42%
2025NZ-$7.2032.89%
2024NZ-$5.42-15.56%
2023NZ-$6.4114.29%
2022NZ-$5.6116.67%
2021NZ-$4.81-90.86%
2020NZ-$52.64-2.96%
2019NZ-$54.24-63.09%
2018NZ-$146.96-49.63%
2017NZ-$291.78-57.87%
2016NZ-$692.57-74.01%
2015NZ-$2,664-9.18%
2014NZ-$2,934-12.86%
2013NZ-$3,36770.73%
2012NZ-$1,97234.07%
2011NZ-$1,471263.41%
2010NZ-$404.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$15.56-313.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
NZ$16.99-333.25%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
NZ$21.68-397.56%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
NZ-$0.71-90.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
NZ-$0.37-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA